相关实验视频
Updated: Jan 9, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
977
类风湿性关节炎治疗的新前沿:从经典的DMARD到生物药物,再到其他领域
Vanshika1, Puja Gulati2, Ritika Thakur3
1MM College of Pharmacy, MMDU, Mullana, Haryana, India.
Pathology, research and practice
|November 30, 2025
概括
类风湿性关节炎 (RA) 药物开发已经从传统到有针对性的合成和生物疗法. 目前正在进行的研究重点是精准医学,以获得更好的类风湿性关节炎治疗结果.
科学领域:
- 免疫学和风湿病学
- 药理学和药物发现
背景情况:
- 风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,影响全球人口的0.5-1%,导致关节破坏和全身并发症.
- 关节炎的发病包括免疫失调,遗传因素和环境触发因素,需要先进的治疗策略.
研究的目的:
- 提供综合性综述的发展的类风湿性关节炎药物开发.
- 探索RA的分子基础和现有和新兴疗法的作用机制.
主要方法:
- 关于RA病原和治疗策略的文献综述.
- 对传统合成DMARDs (csDMARDs),有针对性的合成DMARDs (tsDMARDs) 和生物DMARDs (bDMARDs) 的分析.
- 检查新兴候选药物和RA治疗的未来方向.
主要成果:
- 通过csDMARDs,tsDMARDs (例如,JAK抑制剂) 和bDMARDs (例如,TNF和IL-6抗剂) 在RA治疗中取得显著进展.
- 确定驱动RA的关键分子通路,为向治疗的发展提供信息.
- 新兴候选药物显示出提高疗效和个性化治疗的前景.
结论:
- 尽管取得了进展,但在实现完全缓解和管理患者变化方面仍然存在挑战.
- 精准医学和新型免疫病理学引导的方法对于持续的RA疾病控制至关重要.
- 对RA免疫病理学的持续研究对于开发个性化和有效的疗法至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
457
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
457
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Rheumatic Heart Disease III: Medical Management
267
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
267
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K

